Vaccine and Treatment Evaluation Unit at Saint Louis University - DMID 20-0034
$753,743UM1FY2021AINIH
Saint Louis University, Saint Louis MO
Investigators
Linked publications, trials & patents
Paper 39774938Paper 39325506Paper 39040211Paper 38657001Paper 38537255Paper 38408357Paper 38361992Paper 38332733Paper 38019956Paper 37738833Paper 37561027Paper 37466221Paper 37440227Paper 37383244Paper 37206623Paper 37075127Paper 36689221Paper 36131321Paper 35818363Paper 35734087Paper 35139271Paper 34672949Paper 34409989Paper 34379740Paper 34278310Paper 33882225Paper 33378609Paper 33306283Paper 32445440
Abstract
Saint Louis University (SLU) seeks to expand its service to the Vaccine and Treatment Evaluation Unit (VTEU) network providing resources and expertise to help the network achieve its objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics for COVID-19.
View original record on NIH RePORTER →